Home › Funds › Longaeva Partners L.P. › ALNY
Longaeva Partners L.P. position in ALNY
ALNYLAM PHARMACEUTICALS INC · Health Care
Longaeva Partners L.P. reported holding 110,261 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$33.2M, representing 0.76% of its reported portfolio and ranking #27 among its reported holdings. Longaeva Partners L.P. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Longaeva Partners L.P.'s ALNY position evolved
Longaeva Partners L.P. first disclosed a stake in ALNY in Q2 2026 at 110,261 shares (US$33.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 110.26K | $33.19M | New |
About ALNY and 13F data
ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$734.5M), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALNY
- T. Rowe Price Investment Management, Inc. 5.64M sh · $1.70B · Q2 2026
- Baillie Gifford & Co 2.44M sh · $734.48M · Q2 2026
- Orbis Allan Gray Ltd 1.99M sh · $598.27M · Q2 2026
- Two Sigma Investments 1.88M sh · $564.71M · Q2 2026
- AMERICAN CENTURY COMPANIES INC 1.85M sh · $558.10M · Q2 2026
- TWO SIGMA ADVISERS, LP 1.13M sh · $450.36M · Q4 2025
- Deep Track Capital, LP 825.00K sh · $248.35M · Q2 2026
- Qube Research & Technologies Ltd 798.72K sh · $240.44M · Q2 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 729.63K sh · $219.64M · Q2 2026
- LOOMIS SAYLES & CO L P 580.19K sh · $174.65M · Q2 2026
More on Longaeva Partners L.P.
FAQ
How long has Longaeva Partners L.P. held ALNY?
Longaeva Partners L.P. has disclosed ALNY holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Longaeva Partners L.P.'s current position in ALNY?
As of Q2 2026, Longaeva Partners L.P. holds 110.26K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $33.19M, representing 0.76% of its reported portfolio and ranking #27.
Has Longaeva Partners L.P. been buying or selling ALNY?
In the latest 13F filing (Q2 2026), Longaeva Partners L.P. newly opened its position in ALNY.
Which other funds hold ALNY?
Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.